Russell J. Spjut, PharmD

News
The Value of Monotherapies for RA
12/21/2017
Many novel treatments for rheumatoid arthritis have come to the market recently, giving patients options but leaving payers wondering about efficacy and costs.
Many novel treatments for rheumatoid arthritis have come to the market recently, giving patients options but leaving payers wondering about efficacy and costs.
Many novel treatments for...
12/21/2017
First Report Managed Care
Department
A Hard Look at the Cost of Cancer Therapy
08/30/2017
With limited success and skyrocketing costs, it could be time for the United States to take a hard look at the societal impact of current cancer therapy coverage practices. Countries like the United Kingdom and Sweden could provide a starting...
With limited success and skyrocketing costs, it could be time for the United States to take a hard look at the societal impact of current cancer therapy coverage practices. Countries like the United Kingdom and Sweden could provide a starting...
With limited success and...
08/30/2017
First Report Managed Care
Department
Overkill: High Cost Drugs for Common Condition
07/03/2017
Complex, curative agents have been a godsend for debilitating chronic disease states; however, trends indicate that development of these high-priced drugs for common conditions could have an negative effect.
Complex, curative agents have been a godsend for debilitating chronic disease states; however, trends indicate that development of these high-priced drugs for common conditions could have an negative effect.
Complex, curative agents have...
07/03/2017
First Report Managed Care
Formulary Frontlines®
Breakthroughs in ALS Treatment
09/25/2017
An outpouring of social awareness for amyotrophic lateral sclerosis research has led to the first new drug approved for treatment of the disease in 20 years.
An outpouring of social awareness for amyotrophic lateral sclerosis research has led to the first new drug approved for treatment of the disease in 20 years.
An outpouring of social...
09/25/2017
First Report Managed Care
Formulary Frontlines®
Breakthroughs in Acute Myeloid Leukemia
10/26/2017
S Russell Spjut, PharmD, discusses current first-line therapies and new treatment opions used to treat acute myeloid leukemia and their associated costs. 
S Russell Spjut, PharmD, discusses current first-line therapies and new treatment opions used to treat acute myeloid leukemia and their associated costs. 
S Russell Spjut, PharmD,...
10/26/2017
First Report Managed Care
Formulary Frontlines®
Assessing Diabetes Treatment Options
05/17/2019
Russel Spjut, PharmD, discusses various treatment options for diabetes, as well as explores the most recent technologies aimed at improving management of the disease.
Russel Spjut, PharmD, discusses various treatment options for diabetes, as well as explores the most recent technologies aimed at improving management of the disease.
Russel Spjut, PharmD, discusses...
05/17/2019
First Report Managed Care
Pharmacy Insight
Runaway Drug Price Increases: Unsustainable Price Increases Burden Pharmacy Spending
06/08/2017
Yearly incremental drug price increases are becoming an unsustainable burden on specialty pharmacy spending.
Yearly incremental drug price increases are becoming an unsustainable burden on specialty pharmacy spending.
Yearly incremental drug price...
06/08/2017
First Report Managed Care
Pharmacy Insight
Competition, Preferences Within a New Class of Drugs
11/28/2018
A few months ago, I wrote an article about my initial impressions of the landscape of calcitonin gene-related peptide (CGRP) receptor antagonists for the treatment of migraines just after the launch of the first drug approved in this class,...
A few months ago, I wrote an article about my initial impressions of the landscape of calcitonin gene-related peptide (CGRP) receptor antagonists for the treatment of migraines just after the launch of the first drug approved in this class,...
A few months ago, I wrote an...
11/28/2018
First Report Managed Care
Pharmacy Insight
Increasing OTC Drug Availability Could Significantly Decrease Payer Spending
08/30/2018
Increasing access to medications without a prescription, when properly done, has the potential to positively impact many interested parties.
Increasing access to medications without a prescription, when properly done, has the potential to positively impact many interested parties.
Increasing access to medications...
08/30/2018
First Report Managed Care

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use